In addition, the expression of glutamate dehydrogenase 1 (GLUD1) and glutamate dehydrogenase 2 (GLUD2) is also upregulated in NPC cells, and they catalyse the conversion of glutamate to α–ketoglutarate (81). The gene discussed is GLUD1; the disease is nasopharyngeal carcinoma.